These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22914306)

  • 21. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
    Laynez A; Sardi G; Hauville C; Barbash IM; Pakala R; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):759-65. PubMed ID: 22488756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in management and outcome of acute myocardial infarctions treated in 2006-2007.
    Halvorsen S; Eritsland J; Abdelnoor M; Holst Hansen C; Risøe C; Midtbø K; Bjørnerheim R; Mangschau A
    Cardiology; 2009; 114(2):83-8. PubMed ID: 19420934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna) multicenter registry.
    Valgimigli M; Saia F; Guastaroba P; Menozzi A; Magnavacchi P; Santarelli A; Passerini F; Sangiorgio P; Manari A; Tarantino F; Margheri M; Benassi A; Sangiorgi MG; Tondi S; Marzocchi A;
    JACC Cardiovasc Interv; 2012 Jan; 5(1):23-35. PubMed ID: 22230147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention.
    Jakobsen L; Niemann T; Thorsgaard N; Thuesen L; Lassen JF; Jensen LO; Thayssen P; Ravkilde J; Tilsted HH; Mehnert F; Johnsen SP
    Circ Cardiovasc Interv; 2012 Oct; 5(5):641-8. PubMed ID: 23031837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction.
    Velders MA; Boden H; van Boven AJ; van der Hoeven BL; Heestermans AA; Cannegieter SC; Umans VA; Jukema JW; Hofma SH; Schalij MJ
    Am J Cardiol; 2013 Feb; 111(3):312-8. PubMed ID: 23159214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of female sex on long-term outcomes in patients with ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Ferrante G; Corrada E; Belli G; Zavalloni D; Scatturin M; Mennuni M; Gasparini GL; Bernardinelli L; Cianci D; Pastorino R; Rossi ML; Pagnotta P; Presbitero P
    Can J Cardiol; 2011; 27(6):749-55. PubMed ID: 21924580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of bleeding complications and 3-year survival with low-molecular-weight heparin versus unfractionated heparin for acute myocardial infarction: the FAST-MI registry.
    Puymirat É; Aissaoui N; Silvain J; Bonello L; Cuisset T; Motreff P; Bataille V; Durand E; Cottin Y; Simon T; Danchin N;
    Arch Cardiovasc Dis; 2012; 105(6-7):347-54. PubMed ID: 22800719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial infarction: from the Western Denmark heart registry.
    Antonsen L; Jensen LO; Terkelsen CJ; Tilsted HH; Junker A; Maeng M; Hansen KN; Lassen JF; Thuesen L; Thayssen P
    Catheter Cardiovasc Interv; 2013 May; 81(6):912-9. PubMed ID: 22887706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database.
    Milcent C; Dormont B; Durand-Zaleski I; Steg PG
    Circulation; 2007 Feb; 115(7):833-9. PubMed ID: 17309933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-hospital management and outcome in women with acute myocardial infarction (data from the AMI-Florence Registry).
    Carrabba N; Santoro GM; Balzi D; Barchielli A; Marchionni N; Fabiani P; Landini C; Scarti L; Santoro G; Valente S; Verdiani V; Buiatti E;
    Am J Cardiol; 2004 Nov; 94(9):1118-23. PubMed ID: 15518604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
    Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
    Jones DA; Rathod KS; Gallagher S; Weerackody R; Knight CJ; Rothman MT; Mathur A; Jain AK; Timmis AD; Wragg A
    Catheter Cardiovasc Interv; 2013 May; 81(6):E237-44. PubMed ID: 22707383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
    Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
    Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year.
    Stolker JM; Cohen DJ; Kennedy KF; Pencina MJ; Lindsey JB; Mauri L; Cutlip DE; Kleiman NS;
    Circ Cardiovasc Interv; 2012 Dec; 5(6):772-82. PubMed ID: 23093553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction.
    Chen LY; Lennon RJ; Grantham JA; Berger PB; Mathew V; Singh M; Holmes DR; Rihal CS
    Am J Cardiol; 2005 Feb; 95(3):349-54. PubMed ID: 15670543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences and in-hospital mortality in patients undergoing percutaneous coronary interventions.
    Nowakowska-Arendt A; Grabczewska Z; Koziński M; Sukiennik A; Swiatkiewicz I; Grześk G; Radomski M; Bogdan M; Kochman W; Kubica J
    Kardiol Pol; 2008 Jun; 66(6):632-9; discussion 640-1. PubMed ID: 18626832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.